Concerns regarding the readministration of tumor necrosis factor alpha antagonists following tuberculosis flare: comment on the concise communication by Aslanidis et al.
作者信息
Chogle A R, Mishra Hemali, Deo S S
出版信息
Arthritis Rheum. 2008 Sep;58(9):2923-4. doi: 10.1002/art.23790.
PMID:18759280
Abstract
摘要
相似文献
1
Concerns regarding the readministration of tumor necrosis factor alpha antagonists following tuberculosis flare: comment on the concise communication by Aslanidis et al.
Arthritis Rheum. 2008 Sep;58(9):2923-4. doi: 10.1002/art.23790.
2
Is it safe to readminister tumor necrosis factor alpha antagonists following tuberculosis flare?
Arthritis Rheum. 2008 Jan;58(1):327-8. doi: 10.1002/art.23210.
3
Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis.
Rheumatology (Oxford). 2008 May;47(5):738-9. doi: 10.1093/rheumatology/ken113. Epub 2008 Mar 27.
4
Why does tumor necrosis factor targeted therapy reactivate tuberculosis?
J Rheumatol Suppl. 2005 Mar;74:35-9.
5
Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?
J Rheumatol. 2006 Feb;33(2):433; author reply 433-4.
6
[TNF antagonists in therapy of rheumatoid arthritis].
Med Monatsschr Pharm. 1999 Nov;22(11):334-9.
7
Anti-tumor necrosis factor alpha therapy in rheumatoid arthritis: hitting two birds with one stone?
Arthritis Rheum. 2004 Jun 15;51(3):309-10. doi: 10.1002/art.20406.
8
Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade: comment on the article by Buch et al.
Arthritis Rheum. 2005 Jan;52(1):364-5; author reply 365. doi: 10.1002/art.20769.
9
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.
Arthritis Rheum. 2005 Jul;52(7):1986-92. doi: 10.1002/art.21137.
10
Tumor necrosis factor inhibitors for rheumatoid arthritis.
N Engl J Med. 2006 Nov 9;355(19):2047-8; author reply 2048.
Zotero 插件